<< Back To Home

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.

Thursday, 3rd of May 2018 Print

Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination.

Ng SS, Hutubessy R, Chaiyakunapruk N.

Vaccine. 2018 May 3;36(19):2529-2544.

https://www.sciencedirect.com/science/article/pii/S0264410X18303694?via%3Dihub


24760492